Discovery and SAR of novel, potent and selective protein tyrosine phosphatase 1B inhibitors.

A salicylate second site binder was linked to three classes of phosphotyrosine mimetics to produce potent protein tyrosine phosphatase 1B (PTP1B) inhibitors which exhibit significant selectivity against other phosphatases including the most homologous member, TCPTP.

[1]  D. Lawrence,et al.  Acquisition of a Specific and Potent PTP1B Inhibitor from a Novel Combinatorial Library and Screening Procedure* , 2001, The Journal of Biological Chemistry.

[2]  Zhon-Yin Zhang,et al.  Protein–tyrosine phosphatases: Structure, mechanism, and inhibitor discovery , 1998, Biopolymers.

[3]  D. Barford,et al.  Protein-Tyrosine Phosphatase Inhibition by a Peptide Containing the Phosphotyrosyl Mimetic, L-O-Malonyltyrosine (L-OMT) , 1995 .

[4]  M. J. Newman,et al.  Steric hindrance as a basis for structure-based design of selective inhibitors of protein-tyrosine phosphatases. , 2001, Biochemistry.

[5]  D. Ogg,et al.  Synthesis and biological activity of a novel class of small molecular weight peptidomimetic competitive inhibitors of protein tyrosine phosphatase 1B. , 2002, Journal of medicinal chemistry.

[6]  L. Wu,et al.  Utilization of a peptide lead for the discovery of a novel PTP1B-binding motif. , 2001, Journal of medicinal chemistry.

[7]  D. Barford,et al.  Purification and crystallization of the catalytic domain of human protein tyrosine phosphatase 1B expressed in Escherichia coli. , 1994, Journal of molecular biology.

[8]  M. Tremblay,et al.  Coordinated action of protein tyrosine phosphatases in insulin signal transduction. , 2002, European journal of biochemistry.

[9]  X Y Wang,et al.  Small molecule peptidomimetics containing a novel phosphotyrosine bioisostere inhibit protein tyrosine phosphatase 1B and augment insulin action. , 2001, Biochemistry.

[10]  G. Milne,et al.  Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands. , 1999, Journal of medicinal chemistry.

[11]  M. Blaskovich,et al.  Recent discovery and development of protein tyrosine phosphatase inhibitors , 2002 .

[12]  John Wagner,et al.  Impaired Bone Marrow Microenvironment and Immune Function in T Cell Protein Tyrosine Phosphatase–deficient Mice , 1997, The Journal of experimental medicine.

[13]  J. Ermolieff,et al.  Protein tyrosine phosphatase 1B inhibitors for diabetes , 2002, Nature Reviews Drug Discovery.

[14]  D. Barford,et al.  The structure and mechanism of protein phosphatases: insights into catalysis and regulation. , 1998, Annual review of biophysics and biomolecular structure.

[15]  B. Kemp,et al.  The Protein-tyrosine Phosphatase TCPTP Regulates Epidermal Growth Factor Receptor-mediated and Phosphatidylinositol 3-Kinase-dependent Signaling* , 1999, The Journal of Biological Chemistry.

[16]  D S Lawrence,et al.  Identification of a second aryl phosphate-binding site in protein-tyrosine phosphatase 1B: a paradigm for inhibitor design. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Neel,et al.  Protein tyrosine phosphatases in signal transduction. , 1997, Current opinion in cell biology.

[18]  C. Qu.  Role of the SHP-2 tyrosine phosphatase in cytokine-induced signaling and cellular response. , 2002, Biochimica et biophysica acta.

[19]  B. Kennedy,et al.  Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. , 1999, Science.

[20]  I. Hoffmann,et al.  Cell cycle regulation by the Cdc25 phosphatase family. , 2000, Progress in cell cycle research.

[21]  Young-Bum Kim,et al.  Increased Energy Expenditure, Decreased Adiposity, and Tissue-Specific Insulin Sensitivity in Protein-Tyrosine Phosphatase 1B-Deficient Mice , 2000, Molecular and Cellular Biology.

[22]  C. Kahn,et al.  Insulin signalling and the regulation of glucose and lipid metabolism , 2001, Nature.